Hunting for genes in essential tremor

E. Tan,E. Tan,A. Schapira

DOI: https://doi.org/10.1111/j.1468-1331.2008.02226.x

2008-09-01

European Journal of Neurology

Abstract:Essential tremor (ET) is a common movement disorder in adults and the condition has also been reported in children [1,2]. In the vast majority of patients, a positive family history can frequently be elicited. Current evidence suggests that the inheritance of ET can be autosomal dominant or follow a complex inheritance pattern. Efforts to identify ET susceptibility loci have proved challenging. Thus far, linkage analysis studies in Icelandic and North American families have identified three genetic loci in chromosome 3q13 (ETM1) [3], 2p22-p25 (ETM2) [4] and 6p23 [5], where the causative ET genes may be located. As many families do not show evidence for linkage to any of these loci, multiple yet undiscovered ET genes probably exist. Like in other complex disorders, there have been attempts to unravel common genetic risk factors that might contribute to the etiology of apparent sporadic forms of ET [6–12]. Higgins et al. [9] described a putative mutation (A265G) in the HS1-BP3 gene that was found to associate with familial ET. However, the excitement for this observation abated when the variant was subsequently found in normal controls and could not be consistently replicated in patients [10]. More recently, a Ser9Gly variant in the DRD3 gene located in the ETM1 locus was demonstrated to associate with risk and age at onset of ET [11]. The variant also appears to co-segregate with ET in some families [12]. The DRD3 is of interest as it encodes the dopamine D3 receptor, a member of the D2 family of dopamine receptors. D3 receptors may be involved in the regulation of locomotion as DRD3 protein is expressed in the Purkinje cells of the rat cerebellum, which has been implicated in the pathogenesis of ET [11]. In vitro, DRD3 has been shown to mediate ERK activation and the functional Gly9 variant elevates dopamine affinity and dopamine-mediated cyclic-AMP response and prolongs the mitogen-associated protein kinase signal. Replication of a genetic association in independent populations is the litmus test of its validity. Two studies in this issue of EJN attempted to address the replicability involving the DRD3 variant. Vitale et al. [13] in a case control study in the Italian population did not find such an association in their familial ET patients. The authors also genotyped the variant in 76 affected and 20 non-affected subjects from 16 ET families. Co-segregation of the Gly-9 allele was suggested in only three families. However, the strength of this co-segregation is not clear as details were not provided. Inashkina et al. [14] analyzed short tandem repeat markers located within the ETM 1 and ETM2 loci, but no association of these markers with ET was detected in the Latvian population. Furthermore, they found no significant difference in the frequency of the DRD3 Ser9Gly variant between cases and controls. A similar study also did not detect the association in the Asian population [6]. Blair et al. [15] analyzed the association with this variant using linkage analysis, association study and transmission disequilibrium test in a much larger group of ET patients and controls and arrived at a similar conclusion. The failure by various groups to replicate the DRD3 association with ET is disappointing and suggests that the Ser9Gly variant is unlikely to play a major role in ET susceptibility in the majority of patients. However, it is timely to remind ourselves that findings from both hypothesis-generating and replication studies in ET genetic association studies are frequently influenced by various confounding variables. For most published studies, the sample size remains relatively small, the study populations vary (including a mix of familial and sporadic cases), family history is frequently unreliable with no validation [16], and clinical diagnostic criteria are variably applied. To compound these problems, there is significant clinical and genetic heterogeneity among ET patients, and incomplete penetrance is an important confounding factor in linkage analysis. Misdiagnosis can occur as ET can also be an initial presentation of other genetic disorders [17,18]. Several environmental factors have been postulated in ET pathogenesis, and the magnitude of the gene–environmental interaction in the common garden variety of ET is unclear. Because of all these reasons, cautious interpretation of genetic association studies in ET is advised. To surmount these problems, multiple approaches are needed to unravel causative genes of ET. Perhaps, one should focus on selected groups of ET patients who are genetically enriched. In ET families with clear Mendelian inheritance, a mapping–cloning strategy including parametric linkage analysis and candidate gene screening remains the norm. However, long-term follow-up and re-evaluation of the initial analysis of non-affected subjects will be important. In sporadic patients, validation of a link through comparative analysis of linkage disequilibrium and disease-association patterns in the very young onset patients may be potentially fruitful. These can be reinforced by studies involving sibpairs, monozygotic twins, and nuclear families. An understanding of the aetiopathogenesis of a disease and the role that inheritance can play can be an